Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

This study has suspended participant recruitment.
(Temporarily not enrolling patients.)
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
University of Washington Identifier:
First received: August 1, 2013
Last updated: July 31, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)